A Democratic congresswoman and Republican congressman are edging forward in the effort to change how Medicare pays doctors. Here is the original:  Washington Wire: Progress on How Medicare Pays Doctors  Read More →

Also: The FDA warns about bone-strengthening drugs; Washington will pay primary-care doctors more; and a patients’ pain group folds hours after senators announce a probe. View original here: A.M. Vitals: Pfizer Parts With Lipitor  Read More →

Here’s what’s making news this morning: Advocacy groups are finding patients for drug trials. (WSJ).  The matchmaking comes as shortages of volunteers have slowed trials of new treatments for cancer and other diseases. Researchers identify... 

How did last month’s oral arguments before the Supreme Court on the health-overhaul law shift public opinion? Not much, it turns out. Some 43% of respondents in an April poll carried out by the nonpartisan Kaiser Family Foundation had an unfavorable... 

iStockphoto Here’s what’s making health news toda y: FDA Finds New Batch of Counterfeit Avastin (WSJ): The U.S. Food and Drug Administration warned doctors that a second supply of fake Avastin has made its way into the U.S., suggesting more... 

Here’s what’s making health news this morning: Justices Question Health Law (WSJ): The Supreme Court’s conservative justices sharply challenged the Obama administration’s health-care overhaul Tuesday, raising the prospect that... 

Penalties for selling fake medicines would double if a bill passed last night by the U.S. Senate becomes law. The counterfeiting bill, which has not passed the House of Representatives, would boost the maximum penalty for importing and marketing forged... 

House Budget Committee Chairman Rep. Paul Ryan proposes changes to Medicare’s benefit structure. The latest poll from the Kaiser Family Foundation finds most people want to keep Medicare’s basic benefit structure as it is today — though... 

A Komen fundraising race from the fall. It hasn’t been a great week for Susan G. Komen for the Cure, the breast-cancer advocacy group known for its pink-ribbon fundraising efforts. Today the group reversed a decision — made public only Tuesday... 

Prostate-Cancer Drug Studies: The results from two trials of experimental drugs for advanced prostate cancer add to recent progress against the disease, the WSJ reports . Medivation’s MDV3100 extended survival by nearly five months in a 1,199-patient...